Lineage Cell Therapeutics, Inc.
LCTXAMEXHealthcare● Active
$1.21
+$0.02(+1.26%)
Market Cap$301650937
P/E Ratio—
52W High$2.09
52W Low$0.65
Lineage Cell Therapeutics, Inc.（LCTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LCTX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $14.56M | $9.50M | $8.95M | $14.70M | $3.90M |
| Cost of Revenue | $0.84M | $0.33M | $0.67M | $0.73M | $1.43M |
| Gross Profit | $13.71M | $9.16M | $8.27M | $13.97M | $2.47M |
| Gross Margin %(computed) | 94.19% | 96.48% | 92.50% | 95.05% | 63.40% |
| Operating Expenses | |||||
| R&D Expenses | $17.73M | $12.47M | $15.71M | $13.99M | $33.91M |
| G&A Expenses | $18.46M | $18.17M | $17.30M | $22.51M | $18.21M |
| Total Operating Expenses | $35.49M | $30.64M | $33.01M | $36.49M | $51.68M |
| Operating Income | ($21.78M) | ($21.48M) | ($24.73M) | ($22.52M) | ($49.21M) |
| Operating Margin %(computed) | -149.62% | -226.11% | -276.50% | -153.17% | — |
| Interest Income | $1.69M | $1.72M | $1.63M | $0.83M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($68.65M) | ($18.58M) | ($23.28M) | ($25.81M) | ($43.27M) |
| Income Tax Expense | ($5.11M) | $0.00M | ($1.80M) | $0.54M | $0.00M |
| Net Income | ($63.53M) | ($18.61M) | ($21.49M) | ($26.27M) | ($43.02M) |
| Net Margin %(computed) | -436.47% | -195.90% | -240.20% | -178.69% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.28 | $-0.09 | $-0.12 | $-0.15 | $-0.26 |
| Wtd Avg Shares | 230.12M | 200.19M | 172.66M | 169.79M | 164.50M |
| EBITDA | ($21.08M) | ($20.87M) | ($24.04M) | ($21.79M) | ($48.34M) |
| EBITDA Margin %(computed) | -144.82% | -219.70% | -268.76% | -148.22% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Lineage Cell Therapeutics, Inc.
关于Lineage Cell Therapeutics, Inc.（LCTX）损益表
Lineage Cell Therapeutics, Inc.（LCTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LCTX实现营收$0.01B，毛利润$0.01B（毛利率94.19%），净利润($0.06B)（净利率-436.47%）。
常见问题
LCTX · 4 问Lineage Cell Therapeutics, Inc.（LCTX）2025财年营收为$0.01B，同比up53.2%。
LCTX revenueLCTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08